Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Development of cladribine at Scripps for hairy cell leukemia and current results.
[Results of a comparative clinical trial of the Russian Β - interferon-1b bioanalogue (infibeta)].
Alemtuzumab
Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. II. MRI analysis results of a multicenter, randomized, double-blind, placebo-controlled trial. UBC MS/MRI Study Group and the IFNB Multiple Sclerosis Study Group.
Development of experimental autoimmune encephalomyelitis (EAE) in mice requires vitamin D and the vitamin D receptor.
Interferon Beta-1b may reverse axonal dysfunction in multiple sclerosis.
Patient Satisfaction with the New Interferon Beta-1b Autoinjector (BETACONNECT™).
Ustekinumab success in refractory Crohn’s disease
Individual axons regulate the myelinating potential of single oligodendrocytes in vivo.
GNbAC1, a humanized monoclonal antibody against the envelope protein of multiple sclerosis-associated endogenous retrovirus: a first-in-humans randomized clinical study.
Rituximab in relapsing and progressive forms of multiple sclerosis: a systematic review.
The influence of patient demographics, disease characteristics and treatment on brain volume loss in Trial Assessing Injectable Interferon vs FTY720 Oral in Relapsing-Remitting Multiple Sclerosis (TRANSFORMS), a phase 3 study of fingolimod in multiple scl
Glatiramer acetate ameliorates experimental autoimmune neuritis.
TGFβ Signaling Regulates the Timing of CNS Myelination by Modulating Oligodendrocyte Progenitor Cell Cycle Exit through SMAD3/4/FoxO1/Sp1.
Intas launches biosimilar version of Rituximab
Inflammatory cortical demyelination in early multiple sclerosis.
Risks vs benefits of glatiramer acetate: a changing perspective as new therapies emerge for multiple sclerosis.
Antigen-specific tolerance by autologous myelin Peptide-coupled cells: a phase 1 trial in multiple sclerosis.
Clinically feasible MTR is sensitive to cortical demyelination in MS.
Dose titration of BAF312 attenuates the initial heart rate reducing effect in healthy subjects.
Refining diagnosis of multiple sclerosis with revised MRI criteria.
The relation between inflammation and neurodegeneration in multiple sclerosis brains.
Glatiramer acetate in the treatment of multiple sclerosis
[Experience of using genfaxon for treating patients with relapsing-remitting multiple sclerosis in the Russian Federation.]
Regenerative cellular therapies for neurologic diseases.

Pages